Dana-Farber Cancer Institute

SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer (2026) Bidard FC, Barrios C, Bianchini G, Brufsky AM, Chia S, Cortes J, Cristofanilli M, et al. Journal article SERENA-6 visual patient-reported outcomes and safety: camizestrant for emerging ESR1m advanced breast cancer during first-line endocrine-based therapy (2026) Brufsky A, Park YH, Bidard FC, Mayer EL, Janni W, Ma C, Cristofanilli M, et al. Journal article Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial (2026) Turner NC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article Advancing CNS tumor diagnostics with expanded DNA methylation-based classification (2026) Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, Schweizer L, et al. Journal article A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma (2026) Haydu JE, Redd RA, Lei MM, Hochberg EP, Barnes JA, Armand P, Soumerai JD, et al. Journal article Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling (2026) Suissa D, Fidelle M, Reich E, Pham TN, Thomas S, Björk JR, Liu P, et al. Journal article Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study (2026) Kaulen LD, Nayak L, Karschnia P, Kraai I, Galluzzo D, de Groot FA, Witterholt M, et al. Journal article A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification (2026) Maas SL, Tang Y, Stutheit-Zhao E, Rahmanzade R, Blume C, Hielscher T, Zettl F, et al. Journal article AAPM task group 317 report: A joint AAPM and ESTRO report on brachytherapy catheter, needle, and applicator tracking technology (2025) Beaulieu L, Bert C, Borot de Battisti M, Cormack RA, Cunha JAM, Damato AL, Deufel CL, et al. Journal article First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer. (2025) Bidard FC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article